KIORA PHARMACEUTICALS INC, 2026-04-21
An SEC Form D private-offering notice from Encinitas, CA, a $5,000,000 filer-stated offering target in Biotech. Filed 2026-04-21. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing therapies for retinal diseases, including vision-restoring and anti-inflammatory treatments for conditions like retinitis pigmentosa and uveitis.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Slips Technologies, Inc., 2026-04-21, $4M, Los Angeles, CA
- Haylex Laboratories Inc., 2026-04-21, $1.5M, Kerrville, TX
- Aria Networks, Inc., 2026-04-21, $100M, Palo Alto, CA
- Pearl Diagnostics, Inc., 2026-04-21, $11.2M, Baltimore, MD
- Autonomous Cyber, Inc., 2026-04-21, $6M, Sacramento, CA
- Avivomed Inc., 2026-04-21, $12M, Roseville, MN
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.